$0.742
-0.022 (-2.93%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AKBA Prediction & Forecast by Similar Chart Analysis
Alphio's AKBA stock price prediction model matches the current Akebia Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.74 (-0.21%). The 1-week path is $0.77 (+3.10%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Akebia Therapeutics Inc Stock?
Given the current price of $0.5669 and the RSI of 10.705, which indicates the stock is oversold, there may be a potential for a rebound. However, the significant 82.12% decline over the past year and the negative net income of -$8.9 million in Q2 2026 raise serious concerns. The downgrade by Leerink to a $1 target suggests that the market is cautious about Akebia's future performance, making it a sell for now.
AKBA stock price ended at $0.74 on Thursday, after losing -2.93%
Akebia Therapeutics Inc (AKBA) last closed at $0.7422, losing -2.93%. These facts feed the 1-day and 1-week AKBA price prediction above.
Analyst Consensus
Akebia Therapeutics Inc (AKBA): 6 buy, 1 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Akebia Therapeutics Inc (AKBA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches AKBA, ranked by similarity.
Seasonality analysis for AKBA
Historically the probability of a positive October return for AKBA is 68.66%. October offers the highest probability of a positive month at 68.66%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AKBA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $4.05 | $4.09 | $4.46 | +451.67% |
| Nov 2026 | $3.15 | $3.98 | $4.61 | +436.32% |
| Dec 2026 | $2.84 | $3.65 | $4.36 | +391.85% |
In 2026, Akebia Therapeutics Inc (AKBA) is projected to range from $2.84 to $4.61.
Akebia Therapeutics Inc 2026 monthly forecast
In Oct 2026, Akebia Therapeutics Inc is projected to average $4.09, with a low of $4.05 and high of $4.46.
In Nov 2026, Akebia Therapeutics Inc is projected to average $3.98, with a low of $3.15 and high of $4.61.
In Dec 2026, Akebia Therapeutics Inc is projected to average $3.65, with a low of $2.84 and high of $4.36.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.